New Key Statistics Module, Z-Score and F-Score
OTCPK:AXIM Key Ratios
| Market Cap $ M | 2.78 |
| Enterprise Value $ M | 9.92 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.03 |
| Beneish M-Score | -0.62 |
| 10-y EBITDA Growth Rate % | -9.60 |
| 5-y EBITDA Growth Rate % | 18.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.45 |
| EV-to-EBITDA | -1.54 |
| PEG | -- |
| Shares Outstanding M | 278.43 |
| Net Margin (%) | -6,498.84 |
| Operating Margin % | -2,843.02 |
| Pre-tax Margin (%) | -6,498.84 |
| Quick Ratio | 0.02 |
| Current Ratio | 0.02 |
| ROA % (ttm) | -137.05 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -30.85 |
| Dividend Yield % | -- |
| Altman Z-Score | -30.59 |
AXIM Number of Guru Trades
AXIM Volume of Guru Trades
Gurus Latest Trades with OTCPK:AXIM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:AXIM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AXIM Biotechnologies Inc Insider Transactions
No Available Data
News about OTCPK:AXIM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers